| Literature DB >> 35070450 |
Hawon Lee1,2, Andreu Badal2.
Abstract
Dental imaging is one of the most common types of diagnostic radiological procedures in modern medicine. We introduce a comprehensive table of organ doses received by patients in dental imaging procedures extracted from literature and a new web application to visualize the summarized dose information. We analyzed articles, published after 2010, from PubMed on organ and effective doses delivered by dental imaging procedures, including intraoral radiography, panoramic radiography, and cone-beam computed tomography (CBCT), and summarized doses by dosimetry method, machine model, patient age, and technical parameters. Mean effective doses delivered by intraoral, 1.32 (0.60-2.56) μSv, and panoramic, 17.93 (3.47-75.00) μSv, procedures were found to be about1% and 15% of that delivered by CBCT, 121.09 (17.10-392.20) μSv, respectively. In CBCT imaging, child phantoms received about 29% more effective dose than the adult phantoms received. The effective dose of a large field of view (FOV) (>150 cm2) was about 1.6 times greater than that of a small FOV (<50 cm2). The maximum CBCT effective dose with a large FOV for children, 392.2 μSv, was about 13% of theeffective dose that a person receives on average every year from natural radiation, 3110 μSv. Monte Carlo simulations of representative cases of the three dental imaging procedures were then conducted to estimate and visualize the dose distribution within the head. The user-friendly interactive web application (available at http://dentaldose.org) receives user input, such as the number of intraoral radiographs taken, and displays total organ and effective doses, dose distribution maps, and a comparison with other medical and natural sources of radiation. The web dose calculator provides a practical resource for patients interested in understanding the radiation doses delivered by dental imaging procedures.Entities:
Year: 2021 PMID: 35070450 PMCID: PMC8767401 DOI: 10.1155/2021/6924314
Source DB: PubMed Journal: Radiol Res Pract ISSN: 2090-195X
Technical parameters for intraoral, panoramic, and cone-beam computed tomography collected from literature, which were used for Monte Carlo simulations conducted using MC-GPU to estimate dose distribution within the head.
| Parameters | Intraoral | Panoramic | Cone-beam computed tomography |
|---|---|---|---|
| X-ray energy (kVp) | 60 | 73 | 90 |
| Filtration (mm Al) | 3.5 | 2.5 | 2.8 |
| FOV (cm2) | 4 × 3 | 10 × 0.2 | 10 × 10 |
| SRD1 (cm) | 75 | 35 | 50 |
| Rotation angle per view (degree) | 02 | 240 | 360 |
| Number of views per acquisition | 1 | 9153 | 360 |
| Number of X-rays per simulated view | 1011 | 5 × 107 | 5 × 109 |
| Total simulation time (min)3 | 33 | 143 | 760 |
1Source-to-rotation axis distance. 2The rectangular field was rotated 30° cranially. 3Simulation run in an NVIDIA GeForce GTX 1080 GPU.
Figure 1Flowchart of the web application for dental radiation dose calculations and dose display.
Dosimetry method, machine model, phantom age, technical parameters, and effective and organ (bone marrow, brain, salivary gland, and thyroid) doses for intraoral imaging procedures. No simulation-based doses are reported.
| Method | Machine model | Age | Dosimeter | Phantom | Imaging protocols | DAP (mGy × cm2) | kVp | FOV width (cm) | FOV height (cm) | Effective dose (uSv) | Organ dose (uGy) | Reference | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bone marrow | Brain | Salivary gland | Thyroid | ||||||||||||
| Measurement | Gendex Oralix DC | 35 | TLD | ART | Bitewing single image | 60 | 3.5 | 4.5 | 0.85 | 0.50 | 0.00 | 27.00 | 2.00 | Granlund et al. 2015 [ | |
| Measurement | Gendex Oralix DC | 35 | TLD | ART | Full-mouth single image | 60 | 3.5 | 4.5 | 0.83 | 0.33 | 0.00 | 25.11 | 2.94 | Granlund et al. 2015 [ | |
| Measurement | Prostyle | 10 | Gafchromic film | ATOM 706C | Periapical lateral | 7.42 | 66 | 4.5 | 5.5 | 0.60 | 1.20 | 0.30 | 5.50 | 0.00 | Kadesjo et al. 2018 [ |
| Measurement | Prostyle | 10 | Gafchromic film | ATOM 706C | Periapical central | 7.42 | 66 | 4.5 | 5.5 | 0.70 | 0.00 | 0.00 | 0.01 | 0.00 | Kadesjo et al. 2018 [ |
| Measurement | Focus | 35 | TLD | CDP-R1 | Maxillary premolar left | 70 | 4.5 | 3.5 | 2.56 | 0.55 | 6.12 | 45.25 | 24.47 | Li et al. 2020 [ | |
| Measurement | Focus | 35 | TLD | CDP-R1 | Maxillary premolar left | 70 | 4.5 | 3.5 | 2.39 | 1.19 | 7.76 | 33.88 | 18.38 | Li et al. 2020 [ | |
DAP, dose area product; FOV, field of view.
Dosimetry methods, machine model, phantom age, technical parameters, and effective and organ (bone marrow, brain, salivary gland, and thyroid) doses for panoramic imaging procedures.
| Method | Machine model | Age (year) | Dosimeter/MC code | Phantom | Imaging protocols | kVp | Effective dose (uSv) | Organ dose (uGy) | Reference | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bone marrow | Brain | Salivary gland | Thyroid | |||||||||
| Measurement | AZ3000 | 35 | TLD | RANDO | Temporomandibular | 70 | 11.00 | 3.30 | 29.50 | 549.90 | 29.80 | Matsuo et al. 2011 [ |
| Measurement | OP-200 | 35 | TLD | ART | 66 | 10.73 | 9.94 | 10.03 | 311.78 | 27.89 | Han et al. 2013 [ | |
| Measurement | ORTHOPHOS CD | 35 | TLD | ART | 71 | 14.33 | 10.74 | 9.41 | 419.17 | 67.87 | Han et al. 2013 [ | |
| Measurement | ORTHOPHOS XG Plus | 35 | TLD | ART | 69 | 19.06 | 15.99 | 18.41 | 604.05 | 54.60 | Han et al. 2013 [ | |
| Measurement | ProMax | 35 | TLD | ART | 66 | 26.26 | 14.53 | 15.12 | 939.55 | 54.95 | Han et al. 2013 [ | |
| Measurement | Cranex Tome Ceph | 35 | TLD | ART | Jaw | 66 | 19.00 | 11.00 | 26.00 | 1028.00 | 40.00 | Granlund et al. 2015 [ |
| Measurement | Cranex Tome Ceph | 35 | TLD | ART | Dental | 66 | 22.00 | 10.00 | 10.00 | 1182.00 | 48.00 | Granlund et al. 2015 [ |
| Measurement | Veraviewepocs | 35 | TLD | ART | Jaw | 66 | 23.00 | 13.00 | 10.00 | 869.00 | 53.00 | Granlund et al. 2015 [ |
| Measurement | Veraviewepocs | 35 | TLD | ART | Dental | 66 | 30.00 | 18.00 | 5.00 | 939.00 | 52.00 | Granlund et al. 2015 [ |
| Measurement | Scanora | 35 | TLD | ART | Jaw | 66 | 75.00 | 54.00 | 18.00 | 2887.00 | 126.00 | Granlund et al. 2015 [ |
| Measurement | Scanora | 35 | TLD | ART | Dental | 66 | 49.00 | 38.00 | 19.00 | 2428.00 | 111.00 | Granlund et al. 2015 [ |
| Measurement | OP-200 | 5 | TLD | ATOM 705 | Long collimator P1 | 66 | 11.40 | 1.90 | 43.00 | 94.00 | 37.00 | Davis 2015 [ |
| Measurement | OP-200 | 5 | TLD | ATOM 705 | Short collimator P2 | 66 | 7.70 | 1.50 | 19.00 | 103.00 | 30.00 | Davis et al. 2015 [ |
| Measurement | OP-100 | 35 | TLD | RANDO | 73 | 7.15 | 5.00 | 72.00 | 109.00 | 24.00 | Lee et al. 2016 [ | |
| Simulation | OP-100 | 35 | PCXMC | ORNL | 73 | 9.39 | 10.00 | 9.00 | 299.00 | 20.00 | Lee et al. 2016 [ | |
| Measurement | ProMax 2D | 10 | Gafchromic film | ATOM 706C | 62 | 4.10 | 1.80 | 0.00 | 160.00 | 17.00 | Kadesjo et al. 2018 [ | |
| Measurement | ORTHOPHOSXG/Cep | 35 | TLD | RANDO | 64 | 13.00 | 24.00 | 37.00 | 622.00 | 256.00 | Qiang et al. 2019 [ | |
| Measurement | OP-100 | 5 | TLD | ATOM 705-D | 66 | 3.85 | 38.33 | 55.64 | 54.40 | 35.85 | Lee et al. 2019 [ | |
| Simulation | OP-100 | 5 | PCXMC | ORNL | 66 | 3.47 | 10.51 | 20.00 | 4.32 | 13.29 | Lee et al. 2019 [ | |
| Measurement | PP1 | 35 | TLD | CDP-R1 | Maxillofacial | 73 | 8.15 | 8.08 | 33.10 | 113.30 | 54.31 | Li et al. 2020 [ |
| Measurement | PP1 | 35 | TLD | CDP-R1 | Maxillofacial | 73 | 8.99 | 8.34 | 29.59 | 148.55 | 63.90 | Li et al. 2020 [ |
Dosimetry methods, machine model, phantom age, technical parameters, and effective and organ (bone marrow, brain, salivary gland, and thyroid) doses for cone-beam computed tomography procedures.
| Method | Machine model | Age | Dosimeter/MC code | Phantom | Rotation (degree) | Imaging protocols | DAP (mGy × | kVp | FOV width (cm) | FOV height (cm) | Effective dose (uSv) | Organ dose (uGy) | Reference | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bone marrow | Brain | Salivary gland | Thyroid | |||||||||||||
| Measurement | Galileos | 35 | TLD | ART | Maxillofacial | 85 | 15 | 15 | 84.00 | 82.00 | 124.00 | 2104.00 | 380.00 | Pauwels et al. 2012 [ | ||
| Measurement | i-CAT | 35 | TLD | ART | Maxillofacial | 120 | 16 | 13 | 83.00 | 116.00 | 375.00 | 1830.00 | 355.00 | Pauwels et al. 2012 [ | ||
| Measurement | Iluma Elite | 35 | TLD | ART | Maxillofacial | 120 | 21 | 14 | 368.00 | 660.00 | 3415.00 | 7225.00 | 1230.00 | Pauwels et al. 2012 [ | ||
| Measurement | Kodak 9500 | 35 | TLD | ART | Maxillofacial | 90 | 20 | 18 | 136.00 | 206.00 | 1205.00 | 2676.00 | 585.00 | Pauwels et al. 2012 [ | ||
| Measurement | NewTom VG | 35 | TLD | ART | Maxillofacial | 110 | 15 | 10 | 83.00 | 115.00 | 251.00 | 1690.00 | 354.00 | Pauwels et al. 2012 [ | ||
| Measurement | NewTom VGi | 35 | TLD | ART | Maxillofacial | 110 | 15 | 15 | 194.00 | 186.00 | 605.00 | 2855.00 | 2045.00 | Pauwels et al. 2012 [ | ||
| Measurement | Scanora 3D | 35 | TLD | ART | Maxillofacial | 85 | 14.5 | 13.5 | 68.00 | 86.00 | 255.00 | 1568.00 | 296.00 | Pauwels et al. 2012 [ | ||
| Measurement | SkyView | 35 | TLD | ART | Maxillofacial | 90 | 17 | 17 | 87.00 | 134.00 | 719.00 | 1582.00 | 474.00 | Pauwels et al. 2012 [ | ||
| Measurement | 3D Accuitomo 170 | 35 | TLD | ART | Maxilla | 90 | 10 | 5 | 54.00 | 112.00 | 189.00 | 2138.00 | 148.00 | Pauwels et al. 2012 [ | ||
| Measurement | i-CAT NG | 35 | TLD | ART | Mandible | 120 | 16 | 6 | 45.00 | 33.00 | 46.00 | 973.00 | 251.00 | Pauwels et al. 2012 [ | ||
| Measurement | Kodak 9500 | 35 | TLD | ART | Dentoalveolar | 90 | 15 | 8 | 92.00 | 85.00 | 91.00 | 2166.00 | 541.00 | Pauwels et al. 2012 [ | ||
| Measurement | NewTom VGi | 35 | TLD | ART | Dentoalveolar | 110 | 12 | 8 | 265.00 | 294.00 | 431.00 | 6372.00 | 1293.00 | Pauwels et al. 2012 [ | ||
| Measurement | Picasso trio | 35 | TLD | ART | Dentoalveolar | 85 | 12 | 7 | 123.00 | 126.00 | 134.00 | 2982.00 | 551.00 | Pauwels et al. 2012 [ | ||
| Measurement | Picasso trio | 35 | TLD | ART | Dentoalveolar | 85 | 12 | 7 | 81.00 | 62.00 | 39.00 | 1837.00 | 583.00 | Pauwels et al. 2012 [ | ||
| Measurement | ProMax 3D | 35 | TLD | ART | Dentoalveolar | 84 | 8 | 8 | 122.00 | 88.00 | 53.00 | 2576.00 | 1021.00 | Pauwels et al. 2012 [ | ||
| Measurement | ProMax 3D | 35 | TLD | ART | Dentoalveolar | 84 | 8 | 8 | 28.00 | 27.00 | 28.00 | 596.00 | 202.00 | Pauwels et al. 2012 [ | ||
| Measurement | Scanora 3D | 35 | TLD | ART | Dentoalveolar | 85 | 10 | 7.5 | 46.00 | 42.00 | 45.00 | 1285.00 | 148.00 | Pauwels et al. 2012 [ | ||
| Measurement | Scanora 3D | 35 | TLD | ART | Mandible | 85 | 10 | 7.5 | 47.00 | 34.00 | 25.00 | 1052.00 | 352.00 | Pauwels et al. 2012 [ | ||
| Measurement | Scanora 3D | 35 | TLD | ART | Maxilla | 85 | 10 | 7.5 | 45.00 | 37.00 | 31.00 | 1117.00 | 240.00 | Pauwels et al. 2012 [ | ||
| Measurement | Veraviewepocs 3D | 35 | TLD | ART | Dentoalveolar | 70 | 8 | 8 | 73.00 | 55.00 | 40.00 | 1956.00 | 330.00 | Pauwels et al. 2012 [ | ||
| Measurement | 3D Accuitomo 170 | 35 | TLD | ART | Lower jaw, molar region | 90 | 4 | 4 | 43.00 | 37.00 | 37.00 | 2120.00 | 195.00 | Pauwels et al. 2012 [ | ||
| Measurement | Kodak 9000 3D | 35 | TLD | ART | Upper jaw, front region | 70 | 5 | 3.7 | 19.00 | 21.00 | 18.00 | 523.00 | 30.00 | Pauwels et al. 2012 [ | ||
| Measurement | Kodak 9000 3D | 35 | TLD | ART | Lower jaw, molar region | 70 | 5 | 3.7 | 40.00 | 78.00 | 290.00 | 709.00 | 251.00 | Pauwels et al. 2012 [ | ||
| Measurement | Pax-Uni3D | 35 | TLD | ART | Upper jaw, front region | 85 | 5 | 5 | 44.00 | 47.00 | 28.00 | 1073.00 | 209.00 | Pauwels et al. 2012 [ | ||
| Measurement | ProMax 3D | 35 | MOSFET | RANDO RAN102 | 200 | 574 | 8 | 8 | 153.00 | 25.00 | 4.30 | 32.00 | 32.00 | Koivisto et al. 2012 [ | ||
| Simulation | ProMax 3D | 35 | PCXMC | ORNL Phantom | 200 | 574 | 8 | 8 | 131.00 | 6.90 | 2.80 | 41.00 | 8.40 | Koivisto et al. 2012 [ | ||
| Simulation | i-CAT | 35 | EGS4 | ICRP ADULT | 360 | 556 | 16 | 13 | 66.00 | 50.00 | 590.00 | 1270.00 | 80.00 | Morant et al. 2013 [ | ||
| Simulation | i-CAT | 35 | EGS4 | ICRP ADULT | 360 | 476 | 16 | 11 | 58.00 | 40.00 | 310.00 | 1230.00 | 80.00 | Morant et al. 2013 [ | ||
| Simulation | i-CAT | 35 | EGS4 | ICRP ADULT | 360 | 415 | 16 | 10 | 53.00 | 30.00 | 190.00 | 1150.00 | 70.00 | Morant et al. 2013 [ | ||
| Simulation | Accuitomo 170 | 5 | EGSnrc | In-house | 360 | Standard resolution | 90 | 6 | 6 | 172.26 | 1052.00 | 89.00 | 2965.00 | 387.00 | Stratis et al. 2016 [ | |
| Simulation | Accuitomo 170 | 5 | EGSnrc | In-house | 360 | Standard resolution | 90 | 8 | 8 | 297.97 | 1478.00 | 181.00 | 4204.00 | 1919.00 | Stratis et al. 2016 [ | |
| Simulation | Accuitomo 170 | 8 | EGSnrc | In-house | 360 | Standard resolution | 90 | 6 | 6 | 119.35 | 518.00 | 92.00 | 2623.00 | 751.00 | Stratis et al. 2016 [ | |
| Simulation | Accuitomo 170 | 8 | EGSnrc | In-house | 360 | Standard resolution | 90 | 8 | 8 | 228.32 | 986.00 | 181.00 | 3831.00 | 1747.00 | Stratis et al. 2016 [ | |
| Simulation | Accuitomo 170 | 12 | EGSnrc | In-house | 360 | Standard resolution | 90 | 6 | 6 | 111.76 | 607.00 | 42.00 | 1862.00 | 497.00 | Stratis et al. 2016 [ | |
| Simulation | Accuitomo 170 | 12 | EGSnrc | In-house | 360 | Standard resolution | 90 | 8 | 8 | 250.95 | 913.00 | 90.00 | 2961.00 | 2772.00 | Stratis et al. 2016 [ | |
| Simulation | Accuitomo 170 | 35 | EGSnrc | ICRP AF | 360 | Standard resolution | 90 | 6 | 6 | 81.54 | 376.00 | 112.00 | 2830.00 | 175.00 | Stratis et al. 2016 [ | |
| Simulation | Accuitomo 170 | 35 | EGSnrc | ICRP AF | 360 | Standard resolution | 90 | 8 | 8 | 126.68 | 565.00 | 224.00 | 4308.00 | 339.00 | Stratis et al. 2016 [ | |
| Simulation | i-CAT | 35 | PCXMC | ORNL Phantom | 360 | 120 | 16 | 13 | 30.99 | 42.90 | 269.58 | 738.29 | 46.97 | Yeh and Chen 2018 [ | ||
| Simulation | ProMax 3D | 5 | EGSnrc | In-house | Canine XS/ND | 96 | 4.2 | 5.5 | 134.90 | 200.00 | 152.00 | 3558.00 | 214.00 | Marcu et al. 2018 [ | ||
| Simulation | ProMax 3D | 5 | EGSnrc | In-house | Molars XS/ND | 96 | 4.2 | 5.5 | 155.90 | 222.00 | 170.00 | 4352.00 | 256.00 | Marcu et al. 2018 [ | ||
| Simulation | ProMax 3D | 5 | EGSnrc | In-house | Molars XS/ND | 96 | 5 | 5.5 | 220.20 | 23.80 | 15.80 | 336.30 | 67.90 | Marcu et al. 2018 [ | ||
| Simulation | ProMax 3D | 5 | EGSnrc | In-house | Molars XS/ND | 96 | 10 | 9 | 68.60 | 77.70 | 62.70 | 1400.60 | 315.30 | Marcu et al. 2018 [ | ||
| Simulation | ProMax 3D | 5 | EGSnrc | In-house | Molars XS/ND | 96 | 10 | 5.5 | 55.70 | 45.00 | 28.60 | 1211.00 | 308.80 | Marcu et al. 2018 [ | ||
| Simulation | ProMax 3D | 5 | EGSnrc | In-house | Molars XS/ND | 96 | 13 | 16 | 75.60 | 149.60 | 948.20 | 1453.60 | 206.60 | Marcu et al. 2018 [ | ||
| Simulation | ProMax 3D | 5 | EGSnrc | In-house | S/ND | 96 | 23 | 26 | 178.40 | 614.00 | 4324.00 | 1596.00 | 2677.00 | Marcu et al. 2018 [ | ||
| Simulation | ProMax 3D | 8 | EGSnrc | In-house | Canine XS/ND | 96 | 4.2 | 5.5 | 124.60 | 85.00 | 126.00 | 3080.00 | 157.00 | Marcu et al. 2018 [ | ||
| Simulation | ProMax 3D | 8 | EGSnrc | In-house | Molars XS/ND | 96 | 4.2 | 5.5 | 128.60 | 93.00 | 141.00 | 3458.00 | 187.00 | Marcu et al. 2018 [ | ||
| Simulation | ProMax 3D | 8 | EGSnrc | In-house | Molars XS/ND | 96 | 5 | 5.5 | 17.10 | 15.20 | 14.40 | 419.00 | 38.60 | Marcu et al. 2018 [ | ||
| Simulation | ProMax 3D | 8 | EGSnrc | In-house | Molars XS/ND | 96 | 10 | 9 | 60.80 | 54.30 | 48.70 | 1389.00 | 290.90 | Marcu et al. 2018 [ | ||
| Simulation | ProMax 3D | 8 | EGSnrc | In-house | Molars XS/ND | 96 | 10 | 5.5 | 47.90 | 31.70 | 219.00 | 1028.00 | 270.60 | Marcu et al. 2018 [ | ||
| Simulation | ProMax 3D | 8 | EGSnrc | In-house | Molars XS/ND | 96 | 13 | 16 | 64.70 | 104.70 | 772.20 | 1319.00 | 202.60 | Marcu et al. 2018 [ | ||
| Simulation | ProMax 3D | 8 | EGSnrc | In-house | S/ND | 96 | 23 | 26 | 392.20 | 518.00 | 4247.00 | 4007.00 | 2908.00 | Marcu et al. 2018 [ | ||
| Simulation | ProMax 3D | 35 | EGSnrc | ICRP AM | 96 | 23 | 26 | 256.10 | 362.80 | 4653.00 | 4378.00 | 294.00 | Marcu et al. 2018 [ | |||
| Simulation | Cranex3Dx | 35 | MCNP6.1 | ZUBAL Head | 180 | Maxillary first molar/SR | 168 | 90 | 5 | 5 | 40.00 | 375.00 | 105.00 | 1154.00 | 139.00 | Kralik et al. 2018 [ |
| Simulation | Cranex3Dx | 35 | MCNP6.1 | ZUBAL Head | 180 | Mandibular dental arch/SR | 280 | 90 | 6.1 | 7.8 | 75.00 | 370.00 | 55.00 | 1278.00 | 1252.00 | Kralik et al. 2018 [ |
| Simulation | Cranex3Dx | 35 | MCNP6.1 | ZUBAL Head | 180 | Both dental arches | 338 | 90 | 7.8 | 7.8 | 74.00 | 578.00 | 1155.00 | 2045.00 | 535.00 | Kralik et al. 2018 [ |
| Simulation | Cranex3Dx | 35 | MCNP6.1 | ZUBAL Head | 180 | Mandible/SR | 528 | 90 | 7.8 | 15 | 142.00 | 564.00 | 96.00 | 2275.00 | 2465.00 | Kralik et al. 2018 [ |
| Simulation | Cranex3Dx | 35 | MCNP6.1 | ZUBAL Head | 180 | Viscerocranium/SR | 755 | 90 | 13 | 15 | 170.00 | 1034.00 | 552.00 | 2847.00 | 2370.00 | Kralik et al. 2018 [ |
| Simulation | Cranex3Dx | 35 | MCNP6.1 | ZUBAL Head | 360 | Maxillary first molar/SR | 168 | 90 | 5 | 5 | 37.00 | 335.00 | 78.00 | 592.00 | 104.00 | Kralik et al. 2018 [ |
| Simulation | Cranex3Dx | 35 | MCNP6.1 | ZUBAL Head | 360 | Mandibular dental arch/SR | 280 | 90 | 6.1 | 7.8 | 105.00 | 400.00 | 49.00 | 1161.00 | 789.00 | Kralik et al. 2018 [ |
| Simulation | Cranex3Dx | 35 | MCNP6.1 | ZUBAL Head | 360 | Both dental arches | 338 | 90 | 7.8 | 7.8 | 92.00 | 621.00 | 153.00 | 1559.00 | 789.00 | Kralik et al. 2018 [ |
| Simulation | Cranex3Dx | 35 | MCNP6.1 | ZUBAL Head | 360 | Mandible/SR | 528 | 90 | 7.8 | 15 | 184.00 | 607.00 | 87.00 | 2035.00 | 3533.00 | Kralik et al. 2018 [ |
| Simulation | Cranex3Dx | 35 | MCNP6.1 | ZUBAL Head | 360 | Viscerocranium/SR | 755 | 90 | 13 | 15 | 214.00 | 1005.00 | 523.00 | 2371.00 | 3384.00 | Kralik et al. 2018 [ |
| Measurement | ProMax 3D | 10 | TLD | ATOM 706C | 360 | 510 | 90 | 4 | 5 | 88.00 | 130.00 | 510.00 | 1800.00 | 200.00 | Kadesjo et al. 2018 [ | |
| Measurement | NewTom5G | 10 | TLD | ATOM 706C | 360 | 1080 | 110 | 6 | 6 | 172.00 | 270.00 | 760.00 | 3800.00 | 340.00 | Kadesjo et al. 2018 [ | |
| Measurement | Galileos | 35 | TLD | RANDO | Maxillofacial | 85 | 15 | 15 | 203.00 | 278.00 | 636.00 | 7775.00 | 8727.00 | Qiang et al. 2019 [ | ||
| Simulation | CS9300 | 35 | PCXMC | ORNL Phantom | 360 | Facial | 251 | 90 | 17 | 13.5 | 160.90 | 180.00 | 460.00 | 4570.00 | 450.00 | Lee et al. 2020 [ |
| Simulation | CS9300 | 35 | PCXMC | ORNL Phantom | 360 | Dual jaw | 91 | 90 | 10 | 10 | 94.40 | 100.00 | 230.00 | 1950.00 | 580.00 | Lee et al. 2020 [ |
| Simulation | RAYSCAN | 35 | PCXMC | ORNL Phantom | 360 | Large jaw | 177 | 80 | 16 | 10 | 198.00 | 200.00 | 220.00 | 5360.00 | 320.00 | Lee et al. 2020 [ |
| Simulation | RAYSCAN | 35 | PCXMC | ORNL Phantom | 360 | Jaw | 91 | 80 | 10 | 10 | 195.20 | 190.00 | 280.00 | 4700.00 | 410.00 | Lee et al. 2020 [ |
| Measurement | CS9300 | 35 | OSLD | ATOM 702C | 360 | Facial | 251 | 90 | 17 | 13.5 | 181.40 | 20.00 | 1020.00 | 3160.00 | 1210.00 | Lee et al. 2020 [ |
| Measurement | CS9300 | 35 | OSLD | ATOM 702C | 360 | Dual jaw | 91 | 90 | 10 | 10 | 90.70 | 10.00 | 230.00 | 1950.00 | 580.00 | Lee et al. 2020 [ |
| Measurement | RAYSCAN | 35 | OSLD | ATOM 702C | 360 | Large jaw | 177 | 80 | 16 | 10 | 228.50 | 10.00 | 380.00 | 4540.00 | 1680.00 | Lee et al. 2020 [ |
| Measurement | RAYSCAN | 35 | OSLD | ATOM 702C | 360 | Jaw | 91 | 80 | 10 | 10 | 213.80 | 10.00 | 570.00 | 3930.00 | 1500.00 | Lee et al. 2020 [ |
| Measurement | KaVo 3D eXami | 35 | TLD | CDP-R1 | Maxillofacial | 120 | 14.5 | 8.5 | 56.63 | 15.22 | 427.82 | 1177.24 | 476.04 | Li et al. RPD 2020 [ | ||
| Measurement | KaVo 3D eXami | 35 | TLD | CDP-R1 | Maxillofacial | 120 | 14.5 | 8.5 | 55.18 | 11.63 | 494.50 | 1314.85 | 452.68 | Li et al. RPD 2020 [ | ||
DAP, dose area product; FOV, field of view.
Minimum, mean, and maximum values of effective and organ (bone marrow, brain, salivary gland, and thyroid) doses from intraoral, panoramic, and cone-beam computed tomography procedures reported in the selected publications.
| Procedures | Effective dose ( | Organ dose ( | ||||
|---|---|---|---|---|---|---|
| Bone marrow | Brain | Salivary gland | Thyroid | |||
| Intraoral ( | Mean | 1.32 | 0.63 | 2.36 | 22.79 | 7.97 |
| Min | 0.60 | 0.00 | 0.00 | 0.01 | 0.00 | |
| Max | 2.56 | 1.20 | 7.76 | 45.25 | 24.47 | |
|
| ||||||
| Panoramic ( | Mean | 17.93 | 14.66 | 23.28 | 660.24 | 57.93 |
| Min | 3.47 | 1.50 | 0.00 | 4.32 | 13.29 | |
| Max | 75.00 | 54.00 | 72.00 | 2887.00 | 256.00 | |
|
| ||||||
| Cone-beam computed tomography ( | Mean | 121.09 | 254.78 | 471.65 | 2333.95 | 811.16 |
| Min | 17.10 | 6.90 | 2.80 | 32.00 | 8.40 | |
| Max | 392.20 | 1478.00 | 4653.00 | 7775.00 | 8727.00 | |
Minimum, mean, and maximum values of effective and organ (bone marrow, brain, salivary gland, and thyroid) doses from cone-beam computed tomography procedures by age group (children and adults) reported in the selected publications.
| Age group | Effective dose ( | Organ dose ( | ||||
|---|---|---|---|---|---|---|
| Bone marrow | Brain | Salivary gland | Thyroid | |||
| Children ( | Mean | 143.9 | 372.2 | 600.7 | 2393.3 | 759.7 |
| Min | 17.1 | 15.2 | 14.4 | 336.3 | 38.6 | |
| Max | 392.2 | 1478.0 | 4324.0 | 4352.0 | 2908.0 | |
|
| ||||||
| Adults ( | Mean | 111.8 | 207.0 | 419.1 | 2309.7 | 832.1 |
| Min | 19.0 | 6.9 | 2.8 | 32.0 | 8.4 | |
| Max | 368.0 | 1034.0 | 4653.0 | 7775.0 | 8727.0 | |
Minimum, mean, and maximum values of effective and organ (bone marrow, brain, salivary gland, and thyroid) doses from cone-beam computed tomography procedures by field-of-view area (FOV width × height, cm2) reported in the selected publications.
| FOV area (cm2) | Effective dose ( | Organ dose ( | ||||
|---|---|---|---|---|---|---|
| Bone marrow | Brain | Salivary gland | Thyroid | |||
| Small (<50) ( | Mean | 96.5 | 262.8 | 144.2 | 1984.7 | 312.0 |
| Min | 17.1 | 15.2 | 14.4 | 336.3 | 38.6 | |
| Max | 220.2 | 1052.0 | 760.0 | 4352.0 | 1252.0 | |
|
| ||||||
| Medium (50–150) ( | Mean | 113.7 | 246.4 | 184.9 | 2137.2 | 780.7 |
| Min | 28.0 | 6.9 | 2.8 | 32.0 | 8.4 | |
| Max | 298.0 | 1478.0 | 1155.0 | 4700.0 | 3533.0 | |
|
| ||||||
| Large (>150) ( | Mean | 151.4 | 259.3 | 1126.8 | 2887.3 | 1267.7 |
| Min | 31.0 | 10.0 | 124.0 | 738.3 | 47.0 | |
| Max | 392.2 | 1034.0 | 4653.0 | 7775.0 | 8727.0 | |
Minimum, mean, and maximum values of effective and organ (bone marrow, brain, salivary gland, and thyroid) doses from cone-beam computed tomography procedures by age group (children and adults) and field-of-view area (FOV width × height, cm2) reported in the selected publications.
| FOV area (cm2) age group | Effective dose ( | Organ dose ( | |||||
|---|---|---|---|---|---|---|---|
| Bone marrow | Brain | Salivary gland | Thyroid | ||||
| Small (<50) | Children ( | Mean | 131.3 | 292.4 | 192.0 | 2568.5 | 281.4 |
| Min | 17.1 | 15.2 | 14.4 | 336.3 | 38.6 | ||
| Max | 220.2 | 1052.0 | 760.0 | 4352.0 | 751.0 | ||
| Adults ( | Mean | 53.8 | 226.6 | 85.8 | 1271.1 | 349.3 | |
| Min | 19.0 | 21.0 | 18.0 | 523.0 | 30.0 | ||
| Max | 105.0 | 400.0 | 290.0 | 2830.0 | 1252.0 | ||
|
| |||||||
| Medium (50–150) | Children ( | Mean | 144.3 | 512.2 | 115.9 | 2289.2 | 1089.1 |
| Min | 47.9 | 31.7 | 28.6 | 1028.0 | 270.6 | ||
| Max | 298.0 | 1478.0 | 219.0 | 4204.0 | 2772.0 | ||
| Adults ( | Mean | 105.2 | 172.0 | 204.3 | 2094.7 | 694.4 | |
| Min | 28.0 | 6.9 | 2.8 | 32.0 | 8.4 | ||
| Max | 265.0 | 621.0 | 1155.0 | 6372.0 | 3533.0 | ||
|
| |||||||
| Large (>150) | Children ( | Mean | 177.7 | 346.6 | 2572.9 | 2093.9 | 1498.6 |
| Min | 64.7 | 104.7 | 772.2 | 1319.0 | 202.6 | ||
| Max | 392.2 | 614.0 | 4324.0 | 4007.0 | 2908.0 | ||
| Adults ( | Mean | 146.1 | 241.9 | 837.6 | 3046.0 | 1221.5 | |
| Min | 31.0 | 10.0 | 124.0 | 738.3 | 47.0 | ||
| Max | 368.0 | 1034.0 | 4653.0 | 7775.0 | 8727.0 | ||
Figure 2Dose distribution at the level of the lower teeth generated by MC-GPU simulations for (a) intraoral radiography, (b) panoramic radiography, and (c) cone-beam computed tomography.
Figure 3Percent fraction of radiation dose for the different tissues in the head derived from the MC-GPU simulation of the human head phantom exposed to (a) intraoral radiography, (b) panoramic radiography, and (c) cone-beam computed tomography.
Figure 4Web interfaces for (a) user input, (b) organ (brain, salivary gland, bone marrow, thyroid) and effective doses, (c) the fraction of dose in different tissues and 2D and 3D dose distributions, and (d) dose comparison with other radiation sources.